X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6269) 6269
Publication (915) 915
Book Review (770) 770
Book Chapter (18) 18
Dissertation (8) 8
Conference Proceeding (7) 7
Magazine Article (5) 5
Newspaper Article (1) 1
Paper (1) 1
Streaming Video (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5495) 5495
humans (4167) 4167
microbiology (2929) 2929
acinetobacter baumannii - drug effects (2790) 2790
anti-bacterial agents - pharmacology (2775) 2775
microbial sensitivity tests (2313) 2313
infectious diseases (2299) 2299
acinetobacter infections - microbiology (1739) 1739
pharmacology & pharmacy (1738) 1738
acinetobacter baumannii (1649) 1649
acinetobacter-baumannii (1506) 1506
bacteria (1335) 1335
drug resistance, multiple, bacterial (1328) 1328
acinetobacter baumannii - isolation & purification (1262) 1262
female (1258) 1258
male (1235) 1235
pseudomonas-aeruginosa (1196) 1196
acinetobacter baumannii - genetics (1140) 1140
antibiotics (1125) 1125
drug resistance (1101) 1101
acinetobacter infections - drug therapy (1097) 1097
infections (1095) 1095
anti-bacterial agents - therapeutic use (1026) 1026
middle aged (935) 935
gram-negative bacteria (884) 884
drug resistance in microorganisms (869) 869
acinetobacter infections - epidemiology (831) 831
carbapenems - pharmacology (830) 830
cross infection - microbiology (820) 820
drug resistance, bacterial (819) 819
aged (817) 817
adult (808) 808
beta-lactamases - genetics (795) 795
colistin (795) 795
epidemiology (780) 780
escherichia-coli (739) 739
hospitals (724) 724
nosocomial infections (724) 724
biochemical phenomena, metabolism, and nutrition (715) 715
pseudomonas aeruginosa - drug effects (675) 675
resistance (670) 670
health aspects (640) 640
acinetobacter - drug effects (630) 630
bacterial proteins - genetics (629) 629
acinetobacter (619) 619
animals (600) 600
infectious disease (594) 594
antimicrobial resistance (543) 543
bacterial infections and mycoses (527) 527
pneumonia (524) 524
analysis (519) 519
intensive care units (518) 518
research (516) 516
cross infection - epidemiology (514) 514
risk factors (508) 508
klebsiella-pneumoniae (506) 506
infection (497) 497
genes (490) 490
gram-negative bacteria - drug effects (481) 481
outbreak (465) 465
pathogens (457) 457
antimicrobial agents (456) 456
mortality (455) 455
beta-lactamases - metabolism (454) 454
identification (444) 444
acinetobacter baumannii - enzymology (443) 443
strains (442) 442
immunology (439) 439
ventilator-associated pneumonia (437) 437
pseudomonas aeruginosa (435) 435
polycyclic compounds (434) 434
retrospective studies (429) 429
aged, 80 and over (428) 428
cross infection - drug therapy (420) 420
intensive-care-unit (420) 420
colistin - pharmacology (411) 411
risk-factors (411) 411
tigecycline (404) 404
antibacterial agents (390) 390
antibiotic resistance (374) 374
polymerase chain reaction (374) 374
drug resistance, multiple, bacterial - genetics (371) 371
staphylococcus-aureus (366) 366
bacterial proteins - metabolism (365) 365
molecular epidemiology (360) 360
emergence (357) 357
susceptibility (356) 356
antibiotic-resistance (353) 353
minocycline - analogs & derivatives (348) 348
research article (347) 347
klebsiella pneumoniae - drug effects (343) 343
anti-bacterial agents - administration & dosage (339) 339
molecular sequence data (338) 338
treatment outcome (338) 338
bacteremia (329) 329
beta-lactam resistance (329) 329
dna, bacterial - genetics (325) 325
imipenem (324) 324
enterobacteriaceae (316) 316
medicine (316) 316
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6004) 6004
Spanish (82) 82
Chinese (60) 60
Turkish (47) 47
French (38) 38
Japanese (11) 11
Korean (11) 11
Russian (7) 7
Polish (5) 5
Czech (4) 4
German (4) 4
Persian (4) 4
Portuguese (3) 3
Romanian (3) 3
Slovak (3) 3
Arabic (1) 1
Croatian (1) 1
Italian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 05/2015, Volume 60, Issue 9, pp. 1295 - 1303
Background. With an increase in the use of colistin methansulfonate (CMS) to treat carbapenem-resistant Acinetobacter baumannii infections, colistin resistance... 
Acinetobacter baumannii | Molecular typing | Carbapenem resistance | Colistin resistance | Lipid A | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | lipid A | molecular typing | MICROBIOLOGY | IMMUNOLOGY | EMERGENCE | carbapenem resistance | PMRCAB OPERON | SURVEILLANCE | LIPOPOLYSACCHARIDE | colistin resistance | PHOSPHOETHANOLAMINE MODIFICATION | MOLECULAR EPIDEMIOLOGY | MULTIDRUG-RESISTANCE | INSIGHTS | Humans | Middle Aged | Sulbactam - therapeutic use | Male | Acinetobacter Infections - mortality | Multilocus Sequence Typing | Microbial Sensitivity Tests | Carbapenems - pharmacology | Colistin - pharmacology | Drug Resistance, Multiple, Bacterial | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Colistin - therapeutic use | Female | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Lipid A - chemistry | Acinetobacter Infections - microbiology | Pneumonia, Ventilator-Associated - drug therapy | Acinetobacter Infections - complications | Ampicillin - therapeutic use | Acinetobacter Infections - drug therapy | Acinetobacter baumannii - pathogenicity | Ethanolamines - chemistry | Electrophoresis, Gel, Pulsed-Field | Carbapenems - therapeutic use | Pneumonia, Ventilator-Associated - microbiology | Aged | Acinetobacter baumannii - drug effects | Acinetobacter baumannii - genetics | Electronic Health Records | Dosage and administration | Research | Colistin | Drug resistance | Bacterial infections | CRE bacteria | Lipids | Gram-negative bacteria | Mass spectrometry | Drug use | Index Medicus | and Commentaries
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 2017, Volume 61, Issue 10
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2013, Volume 57, Issue 11, pp. 5247 - 5257
Journal Article
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 8/2014, Volume 33, Issue 8, pp. 1311 - 1322
Journal Article
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 8/2013, Volume 57, Issue 3, pp. 349 - 358
Background. Extensively drug-resistant (XDR) Acinetobacter baumannii may cause serious infections in critically ill patients. Colistin often remains the only... 
Intensive care units | Health outcomes | Acinetobacter baumannii | Microbial sensitivity tests | Mortality | Acinetobacter | Infections | Hospitalization | ARTICLES AND COMMENTARIES | Dosage | Arm | Treatment efficacy | Ventilator-associated pneumonia | Antimicrobial therapy | Treatment safety | INFECTIOUS DISEASES | MULTIDRUG-RESISTANT | ventilator-associated pneumonia | antimicrobial therapy | MICROBIOLOGY | IMMUNOLOGY | ATTRIBUTABLE MORTALITY | NOSOCOMIAL INFECTIONS | treatment safety | GRAM-NEGATIVE BACTERIA | GLOBAL SPREAD | mortality | MULTIRESISTANT | MOLECULAR EPIDEMIOLOGY | INTRAVENOUS COLISTIN | CRITICALLY-ILL PATIENTS | treatment efficacy | NEPHROTOXICITY | Length of Stay | Intensive Care Units | Tertiary Care Centers | Humans | Middle Aged | Acinetobacter Infections - drug therapy | Critical Illness | Male | Treatment Outcome | Acinetobacter Infections - mortality | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - methods | Drug Resistance, Multiple, Bacterial | Survival Analysis | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Colistin - therapeutic use | Female | Rifampin - therapeutic use | Aged | Acinetobacter baumannii - drug effects | Usage | Colistin | Patient outcomes | Dosage and administration | Drug therapy, Combination | Drug therapy | Rifampin | Health aspects | Intensive care | Bacterial infections | Clinical trials | Drug resistance | Multivariate analysis | Patients | Index Medicus
Journal Article